-
1
-
-
0041914944
-
Antibodiea that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120
-
Rusche, J.R., Jahaverian, K., McDanal, C, Petro, J., Lynn, D.L, Grimalla, R., et al. 1988. Antibodiea that inhibit fusion of human immunodeficiency virus-infected cells bind a 24-amino acid sequence of the viral envelope, gp120. Proc. Nat. Acad. Sci. 86:3198–3202.
-
(1988)
Proc. Nat. Acad. Sci
, vol.86
, pp. 3198-3202
-
-
Rusche, J.R.1
Jahaverian, K.2
McDanal, C.3
Petro, J.4
Lynn, D.L.5
Grimalla, R.6
-
2
-
-
0024121522
-
Type-specific neutralizatlon of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides
-
Palker, T.J., Clark, M.E., Langlois, A.G., Matthews, T.J., Weinhold, K.J., Randall, R.R., et al. 1988. Type-specific neutralizatlon of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc. Nat. Acad. Sci. 85:1932–1936.
-
(1988)
Proc. Nat. Acad. Sci
, vol.85
, pp. 1932-1936
-
-
Palker, T.J.1
Clark, M.E.2
Langlois, A.G.3
Matthews, T.J.4
Weinhold, K.J.5
Randall, R.R.6
-
3
-
-
0023940408
-
Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope
-
Matsushita, S., Robert-Guroff, M., Rusche, J., Koito, A., Hattori, T, Hoshino, H., et al, 1988. Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. J. Virol. 82:2107–2114.
-
(1988)
J. Virol
, vol.82
, pp. 2107-2114
-
-
Matsushita, S.1
Robert-Guroff, M.2
Rusche, J.3
Koito, A.4
Hattori, T.5
Hoshino, H.6
-
4
-
-
0023693162
-
Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein
-
Skinner, M.A., Ting, R., Langlois, A.J., Weinhold, K.J., Lyerly, H.K., and Matthews, T.J. 1988. Characteristics of a neutralizing monoclonal antibody to the HIV envelope glycoprotein. AIDS Res. Hum. Retroviruses 4:187–194.
-
(1988)
AIDS Res. Hum. Retroviruses
, vol.4
, pp. 187-194
-
-
Skinner, M.A.1
Ting, R.2
Langlois, A.J.3
Weinhold, K.J.4
Lyerly, H.K.5
Matthews, T.J.6
-
5
-
-
0023847810
-
Neutralizing monoolonal antibodies to the AIDS virus
-
Kinney-Thomas, E., Weber, H.N., McClure, J., Clapham, P.R., Singhal, M.C., Shiver, M.K., et al. 1988. Neutralizing monoolonal antibodies to the AIDS virus. AIDS 2:25–29.
-
(1988)
AIDS
, vol.2
, pp. 25-29
-
-
Kinney-Thomas, E.1
Weber, H.N.2
McClure, J.3
Clapham, P.R.4
Singhal, M.C.5
Shiver, M.K.6
-
6
-
-
0024271738
-
Dextran sulfate as an inhibitor against the human immunodeficiency virus
-
Chang, R.S., Tabba, H.D., He, Y, and Smith, K.M. 1988. Dextran sulfate as an inhibitor against the human immunodeficiency virus. Proc. Soc. Exp. Biol. Med. 189:304–309.
-
(1988)
Proc. Soc. Exp. Biol. Med
, vol.189
, pp. 304-309
-
-
Chang, R.S.1
Tabba, H.D.2
He, Y.3
Smith, K.M.4
-
7
-
-
0026019437
-
Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type I without interfering with gp120-CD4 interactions
-
Callahan, L.N., Phelan, M., Mallinson, M., and Noroross, M.A. 1991. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type I without interfering with gp120-CD4 interactions. J. Virol. 65:1543–1550.
-
(1991)
J. Virol
, vol.65
, pp. 1543-1550
-
-
Callahan, L.N.1
Phelan, M.2
Mallinson, M.3
Noroross, M.A.4
-
8
-
-
0026705746
-
The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides
-
Baitinic, D. and Robey, F.A. 1992. The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides. J. Biol. Chem. 267:6664–6671.
-
(1992)
J. Biol. Chem
, vol.267
, pp. 6664-6671
-
-
Baitinic, D.1
Robey, F.A.2
-
9
-
-
0022647159
-
Suramin antiviral therapy in the acquired immunodeficiency syndrome
-
Levine, A.M., Gill, P.S., Cohen, J., Hawkins, J.G., Formenti, S.C., Aguilar, S., et al. 1986. Suramin antiviral therapy in the acquired immunodeficiency syndrome. Ann. Intern. Med. 105:32–37.
-
(1986)
Ann. Intern. Med
, vol.105
, pp. 32-37
-
-
Levine, A.M.1
Gill, P.S.2
Cohen, J.3
Hawkins, J.G.4
Formenti, S.C.5
Aguilar, S.6
-
10
-
-
0026968988
-
Curdlan sulfate and HIV-1: II. In vitro long-term treatment of HIV-1 infectionwith curdlan sulfate
-
Aoki, T., Kaneko, Y, Nguyen, T., Stefanski, M.S., Ting, R.C.Y, and Manak, M.M. 1992. Curdlan sulfate and HIV-1: II. In vitro long-term treatment of HIV-1 infection with curdlan sulfate. AIDS Res. Hum. Retroviruses 8:605–613.
-
(1992)
AIDS Res. Hum. Retroviruses
, vol.8
, pp. 605
-
-
Aoki, T.1
Kaneko, Y.2
Nguyen, T.3
Stefanski, M.S.4
Ting, R.5
Manak, M.M.6
-
11
-
-
0025915506
-
Stilbene disuifonic acids: CD4 antagonists that block human immunodeficiency virus type-1 growth at multiple stages of the virus life cycle
-
Cardin, A.D., Smith, P.L, Hyde, L, Blankenship, D.T., Bowlin, T.L, Schroeder, K., et al. 1991. Stilbene disuifonic acids: CD4 antagonists that block human immunodeficiency virus type-1 growth at multiple stages of the virus life cycle. J. Biol. Chem. 266:13355–13363.
-
(1991)
J. Biol. Chem
, vol.266
, pp. 13355-13363
-
-
Cardin, A.D.1
Smith, P.L.2
Hyde, L.3
Blankenship, D.T.4
Bowlin, T.L.5
Schroeder, K.6
-
12
-
-
0026640187
-
Sulfonic acid dyes: Inhibitlon of the human immunodeficiency virus and mechanism of action
-
Clanton, D.J., Moran, R.A, McMahon, J.B., Weislow, O.S., Buckheit, R.W.J., Hollingshead, M.G., et al. 1992. Sulfonic acid dyes: inhibitlon of the human immunodeficiency virus and mechanism of action. J. AIDS 5:771–781.
-
(1992)
J. AIDS
, vol.5
, pp. 771-781
-
-
Clanton, D.J.1
Moran, R.A.2
McMahon, J.B.3
Weislow, O.S.4
Buckheit, R.W.J.5
Hollingshead, M.G.6
-
13
-
-
0027983025
-
Combinatorially selected guanosine-quartet structure is a potent Inhibitor of human immunodeficiency virus envelope-mediated cell fusion
-
Wyatt, J.R., Vickers, T.A., Roberson, J.L., Buckheit, R.W.J., Klimkait, T, DeBaets, E, et al. 1994. Combinatorially selected guanosine-quartet structure is a potent Inhibitor of human immunodeficiency virus envelope-mediated cell fusion. Proc. Natl. Acad. Sci. 91:1356–1360.
-
(1994)
Proc. Natl. Acad. Sci
, vol.91
, pp. 1356-1360
-
-
Wyatt, J.R.1
Vickers, T.A.2
Roberson, J.L.3
Buckheit, R.W.J.4
Klimkait, T.5
Debaets, E.6
-
14
-
-
0024987667
-
Inhibition of HIV replication by derivatives of naphthalenedisulfonic acids
-
Mohan, R, Sun, D., Thornton, A, and Sari, P.S. 1990. Inhibition of HIV replication by derivatives of naphthalenedisulfonic acids. AIDS 4:821–822.
-
(1990)
AIDS
, vol.4
, pp. 821-822
-
-
Mohan, R.1
Sun, D.2
Thornton, A.3
Sari, P.S.4
-
15
-
-
0026092708
-
Potential anti-AIDS agents. Synthesis and antiviral activity of naphthalenesulfonic acid derivatives against HIV-1 and HIV-2
-
Mohan, R, Singh, R., and Baba, M. 1991. Potential anti-AIDS agents. Synthesis and antiviral activity of naphthalenesulfonic acid derivatives against HIV-1 and HIV-2. J. Med. Chem. 34:212–217.
-
(1991)
J. Med. Chem
, vol.34
, pp. 212-217
-
-
Mohan, R.1
Singh, R.2
Baba, M.3
-
16
-
-
0025987790
-
Pharmacokinetics, toxicity, and activity of intra-venous dextran sulfate in human immunodeficiency virus infection. Antimicrob
-
Flexner, C, Barditch-Crovo, PA, Kornhauser, D.M., Farzadegan, H., Nerhood, LJ., Chaisson, R.E., et al. 1991. Pharmacokinetics, toxicity, and activity of intra-venous dextran sulfate in human immunodeficiency virus infection. Antimicrob. Agents Chemother. 36:2544–2550.
-
(1991)
Agents Chemother
, vol.36
, pp. 2544-2550
-
-
Flexner, C.1
Barditch-Crovo, P.A.2
Kornhauser, D.M.3
Farzadegan, H.4
Nerhood, L.J.5
Chaisson, R.E.6
-
17
-
-
0030002637
-
HIV-1 entry cofactor functional cDNA cloning of a seven-transmembrane, G proteln-coupled receptor
-
Feng, Y, Broder, C.C, Kennedy, P.E., and Berger, EA 1996. HIV-1 entry cofactor functional cDNA cloning of a seven-transmembrane, G proteln-coupled receptor. Science 272:872–877.
-
(1996)
Science
, vol.272
, pp. 872-877
-
-
Feng, Y.1
Broder, C.C.2
Kennedy, P.E.3
Berger, E.A.4
-
18
-
-
15844419153
-
Identification of a major co-receptor for primary isolates of HIV-1
-
Deng, H.-K., Liu, R., Ellmeler, W., Choe, S., Unutmaz, D., Brukhart, M., et al. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661–666.
-
(1996)
Nature
, vol.381
, pp. 661-666
-
-
Deng, H.-K.1
Liu, R.2
Ellmeler, W.3
Choe, S.4
Unutmaz, D.5
Brukhart, M.6
-
20
-
-
0030604727
-
A dual-tropic primary HIV-1 isolate that uses fusin and the B-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors
-
Doranz, B.J., Rucker, J., Yanjie, Y, Smyth, R.J., Samson, M., Peiper, S.C., et al. 1996. A dual-tropic primary HIV-1 isolate that uses fusin and the B-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors. Cell 85:1149–1158.
-
(1996)
Cell
, vol.85
, pp. 1149-1158
-
-
Doranz, B.J.1
Rucker, J.2
Yanjie, Y.3
Smyth, R.J.4
Samson, M.5
Peiper, S.C.6
-
21
-
-
0005014748
-
The ß-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 Isolates
-
Choe, H., Farzan, M., Sun, Y, Sullivan, N., Rollins, B., Ponath, P.D., et al. 1996. The ß-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 Isolates. Cell 88:1185–1148.
-
(1996)
Cell
, vol.88
, pp. 1185-1148
-
-
Choe, H.1
Farzan, M.2
Sun, Y.3
Sullivan, N.4
Rollins, B.5
Ponath, P.D.6
-
22
-
-
0028874048
-
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
-
Ho, D.D., Neumann, A.U., Perelson, A.S., Chen, W., Leonard, J.M., and Markowitz, M. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature 373:123–126.
-
(1995)
Nature
, vol.373
, pp. 123-126
-
-
Ho, D.D.1
Neumann, A.U.2
Perelson, A.S.3
Chen, W.4
Leonard, J.M.5
Markowitz, M.6
-
23
-
-
0028811974
-
Viral dynamics In human immunodeficiency virus type 1 infection
-
Wei, X., Ghosh, S.K, Taylor, M.E., Johnson, V.A., Emini, EA, Deutsch, R, et al. 1995. Viral dynamics In human immunodeficiency virus type 1 infection. Nature 373:117–122.
-
(1995)
Nature
, vol.373
, pp. 117-122
-
-
Wei, X.1
Ghosh, S.K.2
Taylor, M.E.3
Johnson, V.A.4
Emini, E.A.5
Deutsch, R.6
-
24
-
-
0027516822
-
Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS
-
Embretson, J., Zupancic, M., Ribas, J.L., Burke, A., Racz, R, Tenner-Racz, K., et al. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359–362.
-
(1993)
Nature
, vol.362
, pp. 359-362
-
-
Embretson, J.1
Zupancic, M.2
Ribas, J.L.3
Burke, A.4
Racz, R.5
Tenner-Racz, K.6
-
25
-
-
0027538456
-
HIV infection is active and progressive in Iymphoid tissue during the clinically latent stage of disease
-
Pantaieo, G., Graziosi, C, Demarest, J.F., Butini, L., Montroni, M., Fox, C.H., et al. 1993. HIV infection is active and progressive in Iymphoid tissue during the clinically latent stage of disease. Nature 362:355–358.
-
(1993)
Nature
, vol.362
, pp. 355-358
-
-
Pantaieo, G.1
Graziosi, C.2
Demarest, J.F.3
Butini, L.4
Montroni, M.5
Fox, C.H.6
-
26
-
-
0027692154
-
Multifactorial nature of human immunodeficiency virus disease: Implications for therapy
-
Fauci, A. 1993. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 262:1011–1018.
-
(1993)
Science
, vol.262
, pp. 1011-1018
-
-
Fauci, A.1
-
27
-
-
0023867450
-
Soluble CD4 molecules neutralize human immunodeficiency virus type 1
-
Traunecker, A., Luke, W., and Karjaiainen, K. 1988. Soluble CD4 molecules neutralize human immunodeficiency virus type 1. Nature 331:84–86.
-
(1988)
Nature
, vol.331
, pp. 84-86
-
-
Traunecker, A.1
Luke, W.2
Karjaiainen, K.3
-
28
-
-
0023580063
-
Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen
-
Smith, D.H., Bym, R.A., Marsters, SA, Gregory, T, Groopman, J.E., and Capon, D.J. 1987. Blocking of HIV-1 infectivity by a soluble, secreted form of the CD4 antigen. Science 236:1704–1707.
-
(1987)
Science
, vol.236
, pp. 1704-1707
-
-
Smith, D.H.1
Bym, R.A.2
Marsters, S.A.3
Gregory, T.4
Groopman, J.E.5
Capon, D.J.6
-
29
-
-
0023864652
-
A soluble CD4 protein selectively inhibits HIV replication and syncitium formation
-
Hussey, R.E., Richardson, N.E., Kowalski, M., Brown, N.R., Chang, H.-C, Siliciano, R.F., et al. 1988. A soluble CD4 protein selectively inhibits HIV replication and syncitium formation. Nature 331:78–81.
-
(1988)
Nature
, vol.331
, pp. 78-81
-
-
Hussey, R.E.1
Richardson, N.E.2
Kowalski, M.3
Brown, N.R.4
Chang, H.-C.5
Siliciano, R.F.6
-
30
-
-
0026792879
-
Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events
-
Thali, M., Furman, C, Helseth, E., Repke, H., and Sodroski, J. 1992. Lack of correlation between soluble CD4-induced shedding of the human immunodeficiency virus type 1 exterior envelope glycoprotein and subsequent membrane fusion events. J. Vlrol. 66:5516–5524.
-
(1992)
J. Vlrol
, vol.66
, pp. 5516-5524
-
-
Thali, M.1
Furman, C.2
Helseth, E.3
Repke, H.4
Sodroski, J.5
-
31
-
-
13344277279
-
Characterization of siamycin I, a human Immunodeficiency virus fusion inhibitor
-
Lin, P.-R, Simanta, H., Bechtold, C.M., Deminie, CA., Patick, A.K, Alam, M., et al. 1996. Characterization of siamycin I, a human Immunodeficiency virus fusion inhibitor. Antimicrob. Agents Chemother. 40:133–138.
-
(1996)
Antimicrob. Agents Chemother
, vol.40
, pp. 133-138
-
-
Lin, P.-R.1
Simanta, H.2
Bechtold, C.M.3
Deminie, C.A.4
Patick, A.K.5
Alam, M.6
-
32
-
-
1842276413
-
-
Yalpani, M. (ed.). ATL Press, Shrewsbury, MA
-
Uryu, T, Kaneko, Y, Yoshida, T, Mihara, R., Shoji, T, Katsuraya, K., et al. 1993. pp. 101–115 in Carbohydrates and carbohydrate polymers: analysis, biotechnol, modification, antiviral, biomedical, and other applications. Yalpani, M. (ed.). ATL Press, Shrewsbury, MA.
-
(1993)
Carbohydrates and Carbohydrate Polymers: Analysis, Biotechnol, Modification, Antiviral, Biomedical, and Other Applications
, pp. 101-115
-
-
Uryu, T.1
Kaneko, Y.2
Yoshida, T.3
Mihara, R.4
Shoji, T.5
Katsuraya, K.6
-
33
-
-
0025058214
-
Suppression of HIV infection in AZT-treated SCID-hu mice
-
McCune, J.M., Namikawa, R., Shih, C.C., Rabin, L, and Kaneshima, H. 1990. Suppression of HIV infection in AZT-treated SCID-hu mice. Science 247:564–566.
-
(1990)
Science
, vol.247
, pp. 564-566
-
-
McCune, J.M.1
Namikawa, R.2
Shih, C.C.3
Rabin, L.4
Kaneshima, H.5
-
34
-
-
0025996983
-
Non-nucleoside reverse transcriptase Inhibitors that potently and specifically block human immunodeficiency virus type 1 replication
-
Romero, D.L., Busso, M., Tan, C.K., Reusser, F, Palmer, J.R., Poppe, S.M., et al. 1991. Non-nucleoside reverse transcriptase Inhibitors that potently and specifically block human immunodeficiency virus type 1 replication. Proc. Natl. Acad. Sci. 88:8806–8810.
-
(1991)
Proc. Natl. Acad. Sci
, vol.88
, pp. 8806-8810
-
-
Romero, D.L.1
Busso, M.2
Tan, C.K.3
Reusser, F.4
Palmer, J.R.5
Poppe, S.M.6
-
35
-
-
0027270541
-
The RV-43 Study Group, and The ACTG Virology Committee Resistance Working Group. Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type I isolates
-
Japour, A.J., Mayers, D.L., Johnson, V.A., Kuritzkes, D.B., Beckett, LA., Arduino, J.-M., et al. 1993. The RV-43 Study Group, and The ACTG Virology Committee Resistance Working Group. Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type I isolates. Antimicrob. Agents Chemother. 37:1095–1101.
-
(1993)
Antimicrob. Agents Chemother
, vol.37
, pp. 1095-1101
-
-
Japour, A.J.1
Mayers, D.L.2
Johnson, V.A.3
Kuritzkes, D.B.4
Beckett, L.A.5
Arduino, J.-M.6
-
36
-
-
1842401992
-
-
Williams, W.J., Beutler, E., Erslev, A.J., and Lichtman, M.A. (eds). McGraw-Hill, New York
-
Douglaa, S.D. and Hassan, N.F. 1990. pp. 858–868? in Hemotology. Williams, W.J., Beutler, E., Erslev, A.J., and Lichtman, M.A. (eds). McGraw-Hill, New York.
-
(1990)
Hemotology
, pp. 858-868
-
-
Douglaa, S.D.1
Hassan, N.F.2
-
37
-
-
0025304589
-
Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells
-
Ashorn, PA, Berger, EA, and Moss, B. 1990. Human immunodeficiency virus envelope glycoprotein/CD4-mediated fusion of nonprimate cells with human cells. J. Virol. 64:2149–2156.
-
(1990)
J. Virol
, vol.64
, pp. 2149-2156
-
-
Ashorn, P.A.1
Berger, E.A.2
Moss, B.3
-
38
-
-
0025907920
-
Human immunodeficiency virus infection of human-PBL-SCID mice
-
Mosier, D.E., Gulizia, R.J., Baird, S.M., Wilson, D.B., Spector, D.H., and Spector, S.A. 1991. Human immunodeficiency virus infection of human-PBL-SCID mice. Science 251:791–794.
-
(1991)
Science
, vol.251
, pp. 791-794
-
-
Mosier, D.E.1
Gulizia, R.J.2
Baird, S.M.3
Wilson, D.B.4
Spector, D.H.5
Spector, S.A.6
|